Description
Mylotarg is a targeted therapy for AML. Targeted therapies are treatments that act very precisely on cancer cells.
Mylotarg contains a monoclonal antibody attached to a chemotherapy drug. Monoclonal antibodies are drugs made from immune system cells. These drugs attach to specific proteins on cells. Mylotarg attaches to the CD33 protein on the cancerous myeloid cells. It delivers the chemotherapy directly into these cells.
Mylotarg is given by intravenous (IV) infusion. An IV infusion is an injection into a vein that’s given over a period of time. Mylotarg infusions typically last about 2 hours.
You’ll receive these infusions at your doctor’s office, a hospital, or an infusion center. Mylotarg can be used on its own or with other chemotherapy drugs.
Reviews
There are no reviews yet.